1Wise R, Andrews JM, O' Neill P, et al. Pharmacokinetics and distribution in tissue of FK-037, a new parenteral cephalosporin [ J ]. Antimicrob Agents Chemother, 1994,38 ( 10 ):2369.
2Wise R. Tissue penetration of the fourth generation parenteral cephalosporins [ J ]. J Chemother , 1996,8 (2) :63.
4Nagata M, Yasuhara M. Effect of experimental tenal failture on the pharmacodyna mics of cefoselis-induced seizures in rats[J]. Biol Pharm Bull,2001,24(9) :1049.
5Ohki H,Kawabata K,Inamoto Y,et al. Synthesis and antibacterial activity of 3- ( 2 -alkyl-3-aminopyrazolium) cephalosporins related to FK037 [ J]. Bioorg Meal Chem, 1997,5(8) :1685.
6Kazuo S, Kohji K, Kenzi M, et al. New cephem compound and a process for preparation thereof[ P]. EP 307804,1989-03-22.
7Albert L, Jacques D. Derives pyridaziniques [ J ]. Bull Soc Chim France, 1962,1117.
8Hirabayashi S,Ichihara M,Fujii Y,et al. Production of 5-aminopyrazole derivative[ P]. JP 07206826 1995-08-08.
9Nishihira K, Iwata F, Myatake T. Production of 1-substituted 5-aminopyrazole[ P]. JP 1156963,1989-06-20.
10Chang KY, Kim SH, Nam G, et al. Synthesis and structureactivity relationships of quaternary ammonium cephalosporins with 3-pyrazolylpyridinium derivatives [ J ]. Bioorg Med Chem Lett ,2000,10:1211.
3Donald G,Paul R,Pteven P,et al.Use of bistrimethylsilylated intermediates in the preparation of semisynthetic 7-amino-3-substitutedcephems.[J].J Org Chem,1988,52 (12):983.
4Kawabata K,Okuda S,Kishi K,et al.3-Pyrazoliomethylcephem Compounds as Antimicrobial Agents[P].WO:97/41 128,1997-11-06.
5Pandurang BD,Parven KL,Ramakrishna K,et al.Process for the Preparation of Cephalosporins[P].US:20040132995A1,2004-09-08.
